secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001567264-25-000081
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics reduces stockholder quorum to one-third, regains Nasdaq equity compliance after $6.6M raise
--------------------------------------------------------------------------------

- Bylaws amended to require one-third voting power for quorum (down from majority).
- Company raised ~$6.6M in July 2025 via ATM to address Nasdaq equity deficiency.
- Nasdaq confirmed compliance with $2.5M stockholders' equity requirement as of June 30, 2025.
- Nasdaq warned that non-compliance in next periodic report could trigger delisting.
- Q2 10-Q filed Aug 7, 2025, supported the equity position.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000081/0001567264-25-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000081/intensity-20250808.htm
  HTML page:      https://secwatch.observer/filing/0001567264-25-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer